Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/bjc.2014.471 http://scihub22266oqcxt.onion/10.1038/bjc.2014.471 C4453439!4453439!25211658     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Br+J+Cancer 2015 ; 112 (2): 227-31 Nephropedia Template TP {{tp|p=25211658|t=2015. New insights into signalling-pathway alterations in rhabdomyosarcoma |pdf=|usr=}}{{25211658}} gab.com Text New insights into signalling-pathway alterations in rhabdomyosarcoma JO: Br J Cancer http://www.kidney.de/pget.php?&tw=1&pmid=25211658 #FOAvip Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in children and young adults. Several recent studies have shed new light on the alterations in signalling pathways and the downstream effects of these pathway alterations in RMS. Many of these effects converge on the fibroblast growth factor and insulin-like growth-factor pathways. These new findings improve the current understanding of RMS, thus offering novel potential therapeutic targets and strategies that may improve the outcome for patients with RMS. Twit Text FOAVip New insights into signalling-pathway alterations in rhabdomyosarcoma ????Br J Cancer http://www.kidney.de/pget.php?&tw=1&pmid=25211658 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25211658 #FOAvip English Wikipedia <ref>{{Cite pmid|25211658}}</ref> New insights into signalling-pathway alterations in rhabdomyosarcoma #MMPMID25211658 Zhu B; Davie JK Br J Cancer 2015[Jan]; 112 (2): 227-31 PMID25211658show ga Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in children and young adults. Several recent studies have shed new light on the alterations in signalling pathways and the downstream effects of these pathway alterations in RMS. Many of these effects converge on the fibroblast growth factor and insulin-like growth-factor pathways. These new findings improve the current understanding of RMS, thus offering novel potential therapeutic targets and strategies that may improve the outcome for patients with RMS. äNew insights into signalling-pathway alterations in rhabdomyosarcoma (epmc).pdf DeepDyve Pubget Overpricing